Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dormeasan is a traditional herbal medicinal product developed by Bioforce AG (A.Vogel) for the temporary relief of sleep disturbances (insomnia) and mild anxiety. It is a combination of valerian root tincture (*Valeriana officinalis*) and hops strobile tincture (*Humulus lupulus*), formulated as an oral liquid tincture. While the molecular targets are not precisely defined, valerian is believed to modulate GABAergic and adenosine pathways in the central nervous system to promote sedation, while hops provide complementary sedative effects. The product holds a Traditional Herbal Registration (THR) and has been evaluated in Phase 4 clinical trials for non-organic primary insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dormeasan.